Research

The CRB Monitor Securities Research team covers all aspects of the publicly-traded and the privately-held cannabis ecosystem, including the regulatory...

It would be an understatement to say that cannabis equities as a group are not as critical in an asset...

Fourteen states have improved public access to cannabis business licensing information since last year, according to CRB Monitor’s latest state...

We do indeed live in interesting times. The world braces for the era of its first American-born pope; hundreds of...

As the United States raced into the new year with much uncertainty, we witnessed a new government that's intent on...

While the goal of this newsletter is to be effectively a March-only report, as we put it together, it is...

With the current administration (and a few government-adjacent billionaires) calling the shots, the immediate and distant future of all government...

In recent (and distant) memory, there's been little to celebrate in publicly traded cannabis-land. We might speculate that investors in...

As has been the case for longer than we care to remember, most of the CRB equity market failed its...

In the third quarter of 2024, the cannabis licensing landscape across North America presented a mix of stability and strategic...